bioMerieux (BMXMF)
(Delayed Data from OTC)
$122.50 USD
0.00 (0.00%)
Updated Sep 13, 2024 10:22 AM ET
3-Hold of 5 3
C Value B Growth D Momentum C VGM
Industry / Sector Report
Industry : Medical Services
Zacks Industry Rank
Bottom 39% (153 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.40 | 2.02 | 9.99 |
Current Quarter Estimate | NA | 1.50 | 61.00 |
Year Ago Quarter Estimate | NA | 2.64 | 54.84 |
Next Quarter Estimate | NA | 5.18 | 63.00 |
Next Year Estimate | 5.03 | 26.08 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 35.89 | 7.40 | 15.67 |
Next Year | 13.54 | 18.20 | 11.34 |
Last 5 Years | 5.70 | 9.60 | 8.10 |
Next 5 Years | NA | 13.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -3.10 |
Price/Book (MRQ) | 3.57 | 2.05 |
Price/Cash Flow (MRFY) | 23.26 | 13.48 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | NA | -11.31% |
Return on Equity (TTM) | NA | -10.25% |
Debt to Equity (MRQ) | NA | 28.67 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.